Bevacizumab
- Purity: 0.98
- CAS#: 216974-75-3
- Molecular Weight: 149 kDa
- Bioactivity: Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
For research use only.
0 reviews for TargetMol Chemicals